Basic information Safety Related Supplier

ChemicalBook Product Catalog (+)-SJ733

1/1

(+)-SJ733 NEW

$ 199.00 /1mg

Min. Order
Purity99.21%
Cas No1424799-20-1
Supply Ability10g
Update time2024-11-19

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

5YR

United States

show more

Chemical Properties

Product Name	(+)-SJ733
CAS No	1424799-20-1
EC-No
Min. Order
Purity	99.21%
Supply Ability	10g
Release date	2024/11/19

Product Introduction

Bioactivity

Name	(+)-SJ733
Description	(+)-SJ733 (SJ000557733) is a potent Na+-ATPase PfATP4 inhibitor with antimalarial activity for the study of malaria.
In vitro	(+)-SJ733 has not exhibited any significant safety risks at any dose in extensive in vitro profiling, and in any study, there have been no notable safety or tolerability issues (no observed adverse effect level and maximum tolerated dose >240 mg/kg from a 7-day repeat dosing study in rats). Therefore, it is anticipated that (+)-SJ733 has a safety margin of at least 43-fold.[1].
In vivo	(+)-SJ733 is an efficacious and safe orally active drug candidate. (+)-SJ733 is efficacious against P. falciparum 3D70087/N9 in the nonobese diabetic Scid interleukin-2 receptor γ chain null (NSG) mouse model with the (+)-enantiomer exhibiting excellent potency (1.9 mg/kg); similar to pyrimethamine (ED90 0.9 mg/kg) and superior to chloroquine (ED90 4.3 mg/kg) in this model. (+)-SJ733 achieves this efficacy from exposure (AUCED90 1.5 µM⋅h) similar to that of chloroquine (AUCED90 3.1 µM⋅h) and superior to that of pyrimethamine (AUCED90 5.2 µM⋅h) in the same model.(+)-SJ733 exhibits excellent exposure after oral administration in mouse, rat, and dog. In rodents, (+)-SJ733 reaches peak plasma concentrations of ∼5 µM within 1 h after 20–25 mg/kg doses and >20 µM in dogs following a 30 mg/kg oral dose.(+)-SJ733 exhibits no significant toxicology at doses up to 200 mg/kg in rats with an exposure (AUC) ∼43-fold higher than that required to produce the maximum parasitological response (fastest rate of killing) and 220-fold that required to produce the ED90 in the mouse, indicating the potential for an excellent therapeutic ratio[1].
Storage	store at low temperature \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 30 mg/mL (64.05 mM), Sonication is recommended.
Keywords	SJ-733 \| (+)SJ733 \| SJ733 \| SJ 000557733 \| (+)-SJ-733 \| SJ 733 \| (+) SJ733 \| SJ-000557733
Inhibitors Related	Kaempferol \| Sodium oleate \| Hydroxychloroquine \| Metronidazole \| Nitazoxanide \| Doxycycline \| Chloroquine phosphate \| Diethyltoluamide \| Artemisinin \| Benzyl benzoate \| DL-Methionine \| Revaprazan hydrochloride

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book